A Yeast Artificial Chromosome (YAC) Contig Encompassing the Critical Region of the X-Linked Lymphoproliferative Disease (XLP) Locus

• Published in: Genomics (San Diego, Calif.) Calif.), 1997-01, Vol.39 (1), p.55-65
• Main Authors: Lanyi, Arpad, Li, BiFang, Li, ShaoBing, Talmadge, Catherine B., Brichacek, Beda, Davis, Jack R., Kozel, Beth A., Trask, Barbara, van den Engh, Ger, Uzvolgyi, Eva, Stanbridge, Eric J., Nelson, David L., Chinault, Craig, Heslop, Helen, Gross, Thomas G., Seemayer, Thomas A., Klein, George, Purtilo, David T., Sumegi, Janos
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Chromosomes, Artificial, Yeast; Epstein-Barr virus; Flow Cytometry; Genetic Linkage; Genetic Markers; Hematologic and hematopoietic diseases; Humans; Karyotyping; Lymphoproliferative Disorders - genetics; Medical sciences; Medicin och hälsovetenskap; Other diseases. Hematologic involvement in other diseases; Repetitive Sequences, Nucleic Acid; Restriction Mapping; Sequence Deletion; Sequence Tagged Sites; X Chromosome
• ISSN: 0888-7543; 1089-8646
• DOI: 10.1006/geno.1996.4466

X-linked lymphoproliferative disease (XLP) is characterized by a marked vulnerability to Epstein–Barr virus (EBV) infection. Infection of XLP patients with EBV invariably results in fatal mononucleosis, agammaglobulinemia, or malignant lymphoma. Initially the XLP gene was assigned to a 10-cM region in Xq25 between DXS42 and DXS37. Subsequently, an interstitial, cytogenetically visible deletion in Xq25 was identified in one XLP family, 43. In this study we estimated the deletion in XLP patient 43-004 by dual-laser flow karyotyping to involve 2% of the X chromosome, or approximately 3 Mb of DNA sequence. From a human chromosome Xq25-specific yeast artificial chromosome (YAC) sublibrary, five YACs containing DNA sequences deleted in patient 43-004 have been isolated. Sequence-tagged sites (STSs) from these YACs have been used to identify interstitial deletions in unrelated XLP patients. Three more families with interstitial deletions were found. Two of the patients (63-003 and 73-032) carried an interstitial deletion of 3.0 Mb overlapping the 43-004 deletion. In one XLP patient (30-011) who exhibited the characteristic postinfectious mononucleosis phenotype of XLP with hypogammaglobulinemia and malignant lymphoma, a deletion of approximately 250 kb was detected overlapping the deletion detected in patients 43-004, 63-003, and 73-032. A YAC contig of 2.2 Mb spanning the XLP critical region, whose orientation on chromosome X was determined by double-color fluorescencein situhybridization and which consists of 15 overlapping YAC clones, has been constructed. A detailed restriction enzyme map of the region has been constructed. YAC insert sizes were determined by counter-clamped homogenous electric field gel electrophoresis. Chimerism of YACs was determined by FISH and restriction mapping. On the basis of lambda subclones, YAC end-derived plasmids, and STSs with an average spacing of 100 kb, a long-range physical map was constructed using 5 rare-cutter restriction enzymes. The STSs and lambda subclones were used in Southern hybridization and PCR analyses. The work presented here substantially refines the critical region for XLP. The YAC contig with the overlapping interstitial deletions constitutes the basis for the construction of a transcriptional map of the critical region and facilitates the identification of the XLP gene.